Kawashima Y | Gifu Pharmaceutical University
スポンサーリンク
概要
関連著者
-
Kawashima Y
Gifu Pharmaceutical University
-
Takeuchi H
Gifu Pharmaceutical Univ.
-
Yamamoto Hiromitsu
Department Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
Yamamoto Hiromitsu
中華人民共和国
-
TAKEUCHI Hirofumi
Department of Pharmaceutical Engineering, Gifu Pharmaceutical University
-
Kawashima Y
Taisho Pharmaceutical Co. Ltd. Saitama Jpn
-
Kawashima Y
Department Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
Hino Tomoaki
Department Of Nuclear Engineering Hokkaido University
-
KAWASHIMA Yoshiaki
Department of Pharmaceutical Engineering, Gifu Pharmaceutical University
-
KAWASHIMA Yoshiaki
Gifu Pharmaceutical University
-
Hino T
Department Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
Hino Tomoaki
Department Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
Takeuchi H
Gifu Pharmaceutical University
-
Yamamoto H
Department Of Bioengineering Soka University
-
Kurashima Homare
Gifu Pharmaceutical Univ. Gifu Jpn
-
TAKEUCHI Hirofumi
Gifu Pharmaceutical University
-
Takeuchi Hirofumi
Gifu Pharmaceutical Univ.
-
Kobayashi Masao
Product & Technology Development Laboratory Tanabe Seiyaku Co. Ltd.
-
Kawashima Yoshiaki
Department Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
YAMAMOTO Hiromitsu
Gifu Pharmaceutical University
-
Takeuchi Hirofumi
Department Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
Takeuchi Hirofumi
Department of Drug Delivery Technology and Science, Pharmaceutical Engineering, Gifu Pharmaceutical University
-
KUMADA Takashi
Department of Gastroenterology, Ogaki Municipal Hospital
-
HINO Tomoaki
Department of Nuclear Engineering, Hokkaido University
-
Nakano Satoshi
Department Of Gastroenterology Ogaki Municipal Hospital
-
SHIGEYAMA Masato
Department of Pharmacy, Takayama Red Cross Hospital
-
OHGAYA Toyoaki
Department of Pharmacy, Takayama Red Cross Hospital
-
IKEGAMI KAZUHIKO
Pharmaceutical Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
MOMOSE DEN-ICHI
Pharmaceutical Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
Itai S
Pharmaceutics Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Yajima T
Pharmaceutics Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Yajima Toshio
Pharmaceutical Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
SASSA Toshi
Department of Morphologic Diagnosis, Ogaki Municipal Hospital
-
ITAI Shigeru
Pharmaceutics Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
Momose Den-ichi
Pharmaceutical Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Itai Shigeru
Pharmaceutical Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Ikegami Kazuhiko
Pharmaceutical Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Yajima T
Department Of Pharmaceutics Research Center Taisho Pharmaceutical Co. Ltd.
-
齋藤 直樹
Meiji Pharmaceutical University
-
Yamamoto Hiromitsu
Department Of Cardiovascular Medicine Nara Medical University
-
Saito Norio
Chemical Laboratory Meiji-gakuin University
-
Kawashima Yoshiaki
Department of Microbiology and Immunology, Nihon University School of Dentistry at Matsudo
-
Tsujimoto Hiroyuki
HOSOKAWA Powder Technology Research Institute
-
Nagira Shinsuke
Formulation Res. Laboratories Kawashima Res. Eisai Co. Ltd.
-
HIGO Shoichi
Discovery Platform Technology Department, Chugai Pharmaceutical Co., Ltd.
-
HOSHINA WATARU
Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University
-
KURASHIMA HOMARE
Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University
-
TAKEUCHI HIROFUMI
Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University
-
YOKOYAMA TOYOKAZU
Hosokawa Powder Technology Research Institute
-
NAGIRA Shinsuke
Gifu Pharmaceutical University
-
TANIMURA Shinji
Gifu Pharmaceutical University
-
MIMURA KAZUKI
Pharmaceutical Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
OUCHI KIYOHISA
Pharmaceutical Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
KOJIMA Hiroyuki
Gifu Pharmaceutical University
-
Hoshina Wataru
Laboratory Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
SAITO Noriyasu
Pharmaceutical Laboratories, Kissei Pharmaceutical Co., Ltd.,
-
Kurashima Homare
Laboratory Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
Yokoyama Toyokazu
Hosokawa Micron Corp.
-
Higo Shoichi
Discovery Platform Technology Department Chugai Pharmaceutical Co. Ltd.
-
Mimura Kazuki
Pharmaceutical Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Ouchi Kiyohisa
Pharmaceutical Laboratories Kissei Pharmaceutical Co. Ltd.
-
Ouchi Kiyohisa
Pharmaceutical Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Saito Noriyasu
Pharmaceutical Laboratories Kissei Pharmaceutical Co. Ltd.
-
MURAKAMI HIDEKI
Product & Technology Development Laboratory, Tanabe Seiyaku Co., Ltd.
-
KOBAYASHI MASAO
Product & Technology Development Laboratory, Tanabe Seiyaku Co., Ltd.
-
Takeuchi Hirofumi
Laboratory Of Pharmaceutical Engineering Gifu Pharmaceutical University
-
ISSHIKI NOBUYUKI
Pharmaceutical Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
YASUJI Takehiko
Gifu Pharmaceutical University
-
FUKUSHIMA Yumiko
Pharmaceutics Laboratory, Medical Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
Tsujimoto Hiroyuki
Hosokawa Micron Corporation, 1-9 Shoudai, Tajika, Hirakata, Osaka 573-1132, Japan
著作論文
- Slow Release of Tetracycline from a Mucoadhesive Complex with Sucralfate for Eradication of Helicobacter pylori
- Development of Agglomerated Crystals of Ascorbic Acid for Direct Tableting by Spherical Crystallization Technique and Evaluation of Their Compactibilities.
- Formulation Design of Ointment Base Suitable for Healing of Lesions in Treatment of Bedsores.
- Mucoadhesive Liposomes : Physicochemical Properties and Release Behavior of Water-Solubule Drugs from Chitosan-Coated Liposomes.
- Modification of the Physicochemical Properties of Minocycline Hydrochloride Ointment with Cyclodextrines for Optimum Treatment of Bedsore.
- Formulation Design of Ointment Base Suitable for Healing of Lesions in Treatment of Bedsores
- Compaction Properties of Composite Particles Consisting of Lactose with Sodium Alginate Prepared by Spray-Drying.
- Formulation and in vivo evaluation of w/o/w emulsion encapsulating Epirubicin hydrochloride for the transcatheter arterial embolization therapy for hepatocellular carcinoma.
- Prolonged Circulation Time of Doxorubicin-loaded Liposomes Coated with a Modified Polyvinyl Alcohol after Intravenous Injection in Rats.
- Mixed Base of Hydrophilic Ointment and Purified Lanolin to Improve the Drug Release Rate and Absorption of Water of Minocycline Hydrochloride Ointment for Treatment of Bedsores.
- Comparison of Lipiodol Water-in-Oil-in-Water Emulsion and Oil-in-Water Emulsion : Acute Toxicity and Deposition in Liver after Hepatic Arterial Administration in Rats.
- Pulmonary Delivery of Insulin with Nebulized DL-Lactide/Glycolide Copolymer(PLGA) Nanospheres to Prolong Hypoglycemic Effect.
- Modification of the Physicochemical Properties of Minocycline Hydrochloride Ointment with Cyclodextrines for Optimum Treatment of Bedsore
- Surface-modified Antiasthmatic Dry Powder Aerosols Inhaled Intratracheally Reduce the Pharmacologically Effective Dose.
- A New Powder Design Method to Improve Inhalation Efficiency of Pranlukast Hydrate Dry Powder Aerosols by Surface Modification with Hydroxypropylmethylcellulose Phthalate Nanospheres.
- Preparation of Spherically Granulated Crystals of Waxy Drug(Tocopherol Nicotinate) for Direct Tableting by Spherical Crystallization Technique.
- Spray-dried Composite Particles of Lactose and Sodium Alginate for Direct Tabletting and Controlled Releasing.
- Design of Inhalation Dry Powder of Pranlukast Hydrate to Improve Dispersibility by the Surface Modification with Light Anhydrous Silicic Acid(AEROSIL 200)
- Effect of Surface Morphology of Carrier Lactose on Dry Powder Inhalation Property of Pranlukast Hydrate.
- Particle Design of Wogon Extract Dry Powder for Inhalation Aerosols with Granulation Method.
- Engineering of poly(DL-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system
- Tabletting of Solid Dispersion Particles Consisting of Indomethacin and Porous Silica Particles
- A new spherically agglomerated drug composite system with lactose for dry powder inhalation
- Design of rolipram-loaded nanoparticles : comparison of two preparation methods.
- Biodegradable Nanoparticles for Targeted Ddrug Delivery in Treatment of Inflammatory Bowel Disease.
- Mucoadhesive nanoparticulate systems for peptide drug delivery.
- Evaluation of the anti-tumour activity of liposomal doxorubicin coated with hydrophilic polymers in tumour-bearing mice.
- Surface Modification of Liposomes with Various Hydrophilic Polymers Bearing Hydrophobic Anchors and Their Circulation Properties.
- Preparation of a Gel-Forming Ointment Base Applicable to the Recovery Stage of Bedsore and Clinical Evaluation of a Treatment Method with Different Ointment Bases Suitable to each Stage of Bedsore.
- Evaluation of ciruclation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats.
- Passive Tartgeting of Doxorubicin with Polymer Coated Liposomes in Tumor Bearing Rats.
- Passive Targeting of Doxorubicin with Polymer Coated Liposomes in Tumor Bearing Rats
- In Vitro Inhalation Behavior of Spherically Agglomerated Steroid Particles with Carrier Lactose.
- Temperature-Induced Crystallization and Compactibility of Spray Dried Composite Particles Composed of Amorphous Lactose and Various Types of Water-Solbule Polymer.
- Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres coated with Chitosan to Improve Oral Delivery of Elcatonin.
- Formulation of Gel-Formation Ointments with Hydrophilic Polymers for Treatment of Recovery Stage of Bedsore.
- Polymer Coating of Liposomes with a Modified Polyvinyl Alcohol and Their Systemic Circulation and RES Uptake in Rats.
- Enhanced Tumour Accumulation of Doxorubicin with Polymer-coated Liposomes in Rats.
- Evaluation of Acute Toxicity of Epirubicin Hydrochloride-encapsulating w/o/w Emulsion Administered to Rat for the Transcatheter Embolization Therapy for Hepatocellular Carcinoma.
- In Vitro and In Vivo Evaluation of Mini-depot Tablet Prepared Using Poly(DL-lactide-co-glycolide)nanoparticles as Retardant Material.
- Utilization of Poly(DL-lactide-co-glycolide)nanoparticles for Preparation of Mini-depot Tablets by Direct Compression.
- Further Application of a Modified Spontaneous Emulsification Solvent Diffusion Method to Various Types of PLGA and PLA Polymers for Preparation of Nanoparticles.
- Evaluation of Poly(DL-lactide-co-glycolide)Nanoparticles as Matrix Material for Direct Compression.
- Evaluation of poly(DL-lactide-co-glycolide) nanoparticles as matrix material for direct compression
- Preparation of poly(DL-lactide-co-glycolide)nanoparticles by modified spontaneous emulsification solvent diffusion method.
- Influence of the Degrees of Hydrolyzation and Polymerization of Poly(vinylalchol)on the Preparation and Properties of Poly(DL-lactide-co-glycolide)nanoparticle.
- Drug Releasing Properties and Tensile Strength of Dry-Coated Tablets Prepared with Spray-Dried Composite Particles of Lactose and Sodium Alginate.
- Spray-Dried Lactose Composite Particles Containing an Ion Complex of Alginate-Chitosan for Designing a Dry-Coated Tablet Having a Time-Controlled Releasing Function.
- Temperature- and Moisture-Induced Crystallization of Amorphous Lactose in Composite Particles with Sodium Alginate Prepared by Spray-Drying.
- In vitro inhalation behavior of spherically agglomerated steroid particles with carrier lactose
- Temperature-Induced Crystallization and Compactibility of Spray Dried Composite Particles Composed of Amorphous Lactose and Various Types of Water-Soluble Polymer
- The Development of an Aqueous Polymeric Enteric Coating System with Hydroxypropylmethylcellulose Phthalate Nanoparticles
- Physical Stability of Size Controlled Small Unilamellar Liposomes Coated with a Modified Polyvinyl Alcohol.
- Properties of a Peptide Containing DL-Lactide/glycolide Copolymer Nanospheres Prepared by Novel Emulsion Solvent Diffusion Methods.
- Optimum Heat Treatment Conditions for Masking the Bitterness of the Clarithromycin Wax Matrix
- Determination of Optimum Processing Temperature for Transformation of Glyceryt Monostearate
- Method of Evaluation of the Bitterness of Clarithromycin Dry Syrup
- Mixed Base of Hydrophilic Ointment and Purified Lanolin to Improve the Drug Release Rate and Absorption of Water of Minocycline Hydrochloride Ointment for Treatment of Bedsores
- Assessment of Inertial Separation Techniques Used for Pressurized Meterd Dose Inhalers to Evaluat Respiratory Deposition of Aerosolized Wogon Extract Dry Powder in vitro.
- Protective Effects of Chitosan and Liposomal Formulation for Enzymatic Degradation of Insulin and Their Absorption Promoting Effects in Intestinal Mucous Layer.